Department of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.
Bioprocess Biosyst Eng. 2010 Jan;33(1):5-19. doi: 10.1007/s00449-009-0369-y. Epub 2009 Aug 23.
After administration, drugs go through a complex, dynamic process of absorption, distribution, metabolism and excretion. The resulting time-dependent concentration, termed pharmacokinetics (PK), is critical to the pharmacological response from patients. An in vitro system that can test the dynamics of drug effects in a more systematic way would save time and costs in drug development. Integration of microfabrication and cell culture techniques has resulted in 'cells-on-a-chip' technology, which is showing promise for high-throughput drug screening in physiologically relevant manner. In this review, we summarize current research efforts which ultimately lead to in vitro systems for testing drug's effect in PK-based manner. In particular, we highlight the contribution of microscale systems towards this goal. We envision that the 'cells-on-a-chip' technology will serve as a valuable link between in vitro and in vivo studies, reducing the demand for animal studies, and making clinical trials more effective.
给药后,药物经历吸收、分布、代谢和排泄的复杂动态过程。所得的时变浓度,称为药代动力学(PK),对患者的药理反应至关重要。一种能够更系统地测试药物作用动力学的体外系统将节省药物开发的时间和成本。微制造和细胞培养技术的结合产生了“芯片上的细胞”技术,该技术有望以更符合生理的方式进行高通量药物筛选。在这篇综述中,我们总结了当前的研究工作,这些工作最终导致了基于 PK 测试药物作用的体外系统。特别是,我们强调了微尺度系统在这方面的贡献。我们设想,“芯片上的细胞”技术将成为体外和体内研究之间的有价值的联系,减少对动物研究的需求,使临床试验更有效。